RELINT: FPH: Disclosure of Directors relevant interests
Name of director or officer of public issuer: Colin James MAIDEN
Name of public issuer: Fisher & Paykel Healthcare Corporation
Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Director
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: Ordinary Shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial interest
Name of registered holder of securities "(i) Colin James
MAIDEN & Jenefor Mary MAIDEN;
(ii) Colin James Maiden & Jenefor Mary Maiden Trust"
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: (i) & (ii) 9 July 2010
Consideration paid for acquisition: (i) $897.69; (ii) $2,794.80
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: "(i) 300 Ordinary Shares purchased under
the Dividend Reinvestment Plan;
(ii) 934 Ordinary Shares purchased under the Dividend Reinvestment Plan"
E Total number of transactions this notice relates to: (i) One;
(ii) One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 22 December 2009
G Signature
Signature of director or office:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 16 July 2010
Name and title of authorised person: "Antony George Barclay
Chief Financial Officer/Company Secretary"
Name of director or officer of public issuer: Nigel Thomas EVANS
Name of public issuer: Fisher & Paykel Healthcare Corporation
Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Director
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: Ordinary Shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial Ownership
Name of registered holder of securities Nigel Thomas EVANS
and Janette Elizabeth EVANS
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 9 July 2010
Consideration paid for acquisition: $1,235.82
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: 413 Ordinary Shares purchased under the
Dividend Reinvestment Plan
E Total number of transactions this notice relates to: One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 22 December 2009
G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 16 July 2010
Name and title of authorised person: "Antony George Barclay
Chief Financial Officer/Company Secretary"
End CA:00197338 For:FPH Type:RELINT Time:2010-07-16:08:56:41